Assessing the Chemosensitizing Effect of Neferine on Cisplatin-Resistant Colorectal Cancer Cells through Molecular Docking Studies
S. Bharath, S. Gopinath, S. Surovi & V. Vijaya Padma · Journal of Pharmaceutical Research International · 2021
Colorectal cancer (CRC) is the second deadliest diseases next to lung cancer. Cisplatin is the first generation platinum based alkylating agent using for treatment of advance CRC patients. Continuous usages of cisplatin lead to resistance which limits its therapeutic efficacy. Re...
Open access
Research Article
10.9734/jpri/2021/v33i53A33636